Clinical Trial Matcher

NCT03616483

The Indiana Myeloma Registry

Recruiting · Not specified · Indiana University · registry updated 2025-11-10

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Inclusion

  • Male or female patients ≥ 18 years of age at the time of informed consent
  • Has been diagnosed with or is suspected to have one of the following:
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Bony or Soft Tissue Plasmacytoma

Exclusion

  • \< 18 years of age
  • Have not been diagnosed with one of the following:
  • Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Open NCT03616483 on ClinicalTrials.govAll conditions

The Indiana Myeloma Registry | Clinical Trial Matcher